These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16824608)

  • 1. Salvage treatment of histoplasmosis with posaconazole.
    Restrepo A; Tobón A; Clark B; Graham DR; Corcoran G; Bradsher RW; Goldman M; Pankey G; Moore T; Negroni R; Graybill JR
    J Infect; 2007 Apr; 54(4):319-27. PubMed ID: 16824608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole.
    Clark B; Foster R; Tunbridge A; Green S
    J Infect; 2005 Oct; 51(3):e177-80. PubMed ID: 16230202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
    Graybill JR; Palou E; Ahrens J
    Am Rev Respir Dis; 1986 Oct; 134(4):768-70. PubMed ID: 3021035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.
    Connolly P; Wheat LJ; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2604-8. PubMed ID: 10991831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae.
    Kok J; Gilroy N; Halliday C; Lee OC; Novakovic D; Kevin P; Chen S
    J Infect; 2007 Sep; 55(3):e33-6. PubMed ID: 17624436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole as rescue therapy in African histoplasmosis.
    Gonçalves D; Ferraz C; Vaz L
    Braz J Infect Dis; 2013; 17(1):102-5. PubMed ID: 23312726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia.
    Ramos-Ospina N; Carolina Lambertinez-Álvarez I; Johanna Hurtado-Bermúdez L; Patricia Muñoz-Lombo J; Diego Vélez-Londoño J; Andrés Valencia-Montagut J; Andrés Moncada-Vallejo P
    Med Mycol; 2024 Jul; 62(7):. PubMed ID: 38806236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of posaconazole in the treatment of central nervous system fungal infections.
    Pitisuttithum P; Negroni R; Graybill JR; Bustamante B; Pappas P; Chapman S; Hare RS; Hardalo CJ
    J Antimicrob Chemother; 2005 Oct; 56(4):745-55. PubMed ID: 16135526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.
    Segal BH; Barnhart LA; Anderson VL; Walsh TJ; Malech HL; Holland SM
    Clin Infect Dis; 2005 Jun; 40(11):1684-8. PubMed ID: 15889369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imported histoplasmosis].
    Stete K; Kern WV; Rieg S; Serr A; Maurer C; Tintelnot K; Wagner D
    Dtsch Med Wochenschr; 2015 Jun; 140(12):913-6. PubMed ID: 26069920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of central nervous system histoplasmosis.
    Wheat LJ; Musial CE; Jenny-Avital E
    Clin Infect Dis; 2005 Mar; 40(6):844-52. PubMed ID: 15736018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary histoplasmosis.
    McKinsey DS; McKinsey JP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):735-44. PubMed ID: 22167401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
    Wheat LJ; Connolly P; Smedema M; Durkin M; Brizendine E; Mann P; Patel R; McNicholas PM; Goldman M
    J Antimicrob Chemother; 2006 Jun; 57(6):1235-9. PubMed ID: 16627592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
    N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
    Raad II; Hachem RY; Herbrecht R; Graybill JR; Hare R; Corcoran G; Kontoyiannis DP
    Clin Infect Dis; 2006 May; 42(10):1398-403. PubMed ID: 16619151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole.
    Kim MM; Vikram HR; Kusne S; Seville MT; Blair JE
    Clin Infect Dis; 2011 Dec; 53(11):1060-6. PubMed ID: 22045955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated histoplasmosis in renal allograft recipients.
    Peddi VR; Hariharan S; First MR
    Clin Transplant; 1996 Apr; 10(2):160-5. PubMed ID: 8664511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.